Daniel Kotok, | |
4403 Harrison Blvd Ste 4410, Ogden, UT 84403-3323 | |
(801) 387-6850 | |
(801) 387-6855 |
Full Name | Daniel Kotok |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 4403 Harrison Blvd Ste 4410, Ogden, Utah |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427579515 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 13317449-1205 (Utah) | Primary |
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Observing that certain cancer cells may exhibit greater flexibility than normal cells, some scientists believe that this capability promotes rapid tumor growth. Now computer simulations developed by Boston University Biomedical Engineering Assistant Professor Muhammad Zaman and collaborators at the University of Texas at Austin appear to support this view.
Phytomedics, Inc., a transformational healthcare company developing a novel portfolio of drugs and consumer products solely derived from plant sources, announced today that it has been awarded a grant in the amount of $244,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product PMI-001 for Rheumatoid Arthritis. PMI-001 is presently in Phase 2b/3 development.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
Soligenix, Inc., a development stage biopharmaceutical company, announced preliminary results today from a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel Kotok, 4401 Harrison Blvd, Ogden, UT 84403-3195 Ph: () - | Daniel Kotok, 4403 Harrison Blvd Ste 4410, Ogden, UT 84403-3323 Ph: (801) 387-6850 |
News Archive
Observing that certain cancer cells may exhibit greater flexibility than normal cells, some scientists believe that this capability promotes rapid tumor growth. Now computer simulations developed by Boston University Biomedical Engineering Assistant Professor Muhammad Zaman and collaborators at the University of Texas at Austin appear to support this view.
Phytomedics, Inc., a transformational healthcare company developing a novel portfolio of drugs and consumer products solely derived from plant sources, announced today that it has been awarded a grant in the amount of $244,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product PMI-001 for Rheumatoid Arthritis. PMI-001 is presently in Phase 2b/3 development.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
Soligenix, Inc., a development stage biopharmaceutical company, announced preliminary results today from a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.
› Verified 5 days ago
Ewa Gniado, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 Fax: 801-387-7910 | |
Jaclyn Nguyen, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 | |
Dr. Timothy Trask, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-3654 | |
Gregory T Almony, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5405 S 500 E, Suite #204, Ogden, UT 84405 Phone: 801-479-0194 Fax: 801-479-5642 | |
Brian W Pugh, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6028 S Ridgeline Dr, Ste 201, Ogden, UT 84405 Phone: 801-475-5400 Fax: 801-475-8614 | |
Dr. Jack D Wahlen, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd, Ste 3630, Ogden, UT 84403 Phone: 801-387-7900 Fax: 801-387-7910 | |
Gary K Goucher, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd, #3815, Ogden, UT 84403 Phone: 801-387-2575 Fax: 801-387-2585 |